Hematological malignancy - Wikipedia, the free encyclopedia
Hematological malignancies are malignant neoplasms ("cancer"), and they are generally treated by specialists in hematology and/or oncology. ...
http://en.wikipedia.org/wiki/Hematological_malignancy...
|
Heterogeneous CD52 expression among hematologic neoplasms ...
1 Dec 2006 ... The utility of CAMPATH in the treatment of other hematologic neoplasms has been explored; however, a comprehensive survey of CD52 expression ...
http://www.ncbi.nlm.nih.gov/pubmed/17145843...
|
WHO Classification of Hematologic Neoplasms 2008 (2009?)
Hematologic Neoplasms. 2008 (2009?): What's New and Different. Steven H. Kroft, MD. Professor and Director of Hematopathology. Medical College of Wisconsin ...
http://www.mcw.edu/FileLibrary/Groups/Pathology/MidwesternCo...
|
A teaching database for diagnosis of hematologic neoplasms using ...
The interpretation of immunophenotyping results by flow cytometry involves pattern recognition of different hematologic neoplasms that may have similar ...
http://www.ncbi.nlm.nih.gov/pubmed/18466042...
|
Neoplasms - Clinical Trial Listings | Wyeth
Piperacillin/Tazobactam (Tazocin), 0910B1-308, Hematologic Neoplasms,, Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in ...
http://www.wyeth.com/ClinicalTrialListings?query=Neoplasms...
|
Benzene and the dose-related incidence of hematologic neoplasms in ...
PURPOSE: A large cohort study was carried out in China to evaluate the risks of developing specific hematologic neoplasms and selected related disorders in ...
http://www.ncbi.nlm.nih.gov/pubmed/9230889...
|
2 chlorodeoxyadenosine activity and cross resistance patterns in ...
The results suggest 2-CDA activity in many human hematologic neoplasms with the clear exception of multiple myeloma and further suggest a relationship ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19...
|
[Lipid profile in hematologic neoplasms]
[Lipid profile in hematologic neoplasms]. [Article in Italian]. Musolino C, Calabrò L, Bellomo G, Cincotta M, Di Giacomo V, Pezzano C, Loteta B, Rizzo V,
...
http://www.ncbi.nlm.nih.gov/pubmed/12050911...
|
Glucose 6-phosphate dehydrogenase deficiency and incidence of ...
Therefore at present there is no evidence that G6PD deficiency has a protective effect against development of hematologic neoplasms. Full text ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=17...
|
Flow cytometric immunophenotyping for hematologic neoplasms.
Flow cytometric immunophenotyping remains an indispensable tool for the diagnosis, classification, staging, and monitoring of hematologic neoplasms. ...
http://www.ncbi.nlm.nih.gov/pubmed/18198345...
|
